Glutamate neurotransmission system may be involved with depression risk

Researchers using a new approach to identifying genes associated with depression have found that variants in a group of genes involved in transmission of signals by the neurotransmitter glutamate appear to increase the risk of depression. The report published in the journal Translational Psychiatry suggests that drugs targeting the glutamate system may help improve the limited success of treatment with current antidepressant drugs.

Read more at: http://medicalxpress.com/news/2012-11-glutamate-neurotransmission-involved-depression.html#jCp
Enhanced by Zemanta

No comments: